TrialPloS one2021

Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia.

S Shahzad Mustafa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.